Skip to main content
Clinical Trials/CTRI/2024/09/073602
CTRI/2024/09/073602
Not yet recruiting
Phase 3

A Comparative Clinical study to evaluate the effect of Gudaamalaki Kashayam and Atibala Kashayam in the management of Pittaja Mutrakricchram (Lower Urinary Tract Infection)

DrVaishali N1 site in 1 country30 target enrollmentStarted: September 20, 2024Last updated:

Overview

Phase
Phase 3
Status
Not yet recruiting
Sponsor
DrVaishali N
Enrollment
30
Locations
1
Primary Endpoint
Reduction in symptoms of UTI

Overview

Brief Summary

UTI is defined as the presence and multiplication of bacteria in the urinary tract It is associated with a decrease in Quality of life and economical burden to the patients because of its heterogeneous nature with regard to its etiology, clinical manifestation and disease, which range from simple cystitis , urethritis till pyelonephritis, septic shock etc. Urinary tract infection may be of Uncomplicated UTI, Complicated UTI, Upper or Lower UTI. There are UPPER URINARY TRACT INFECTION [UUTI] involving kidney and LOWER URINARY TRACT INFECTION[LUTI] involving urethra, prostate, bladder Mostly 85% of UTI are caused by gram negative bacilli that are normal inhabitants of the intestinal tract. The enteric gram negative rods that have migrated to the urinary tract causes infections. UTIs are common in Pregnancy, Diabetes, Polycysticrenal disease, and in other Immune-compromised patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Subjects having signs and symptoms of Pittaja Mutrakricchram either of the symptoms like Daha, Ruja, Muhur-muhur Vega, Peeta or Rakta Varna Mootra 2.Urine pH of above 7.
  • H/O Recurrent urinary tract infection and uncomplicated urinary tract infection.

Exclusion Criteria

  • 1.K/C/O Renal Calculi, Pyelonephritis, BPH, Urethral Stricture, Phimosis 2.K/C/O Diabetes.
  • 3.Upper Urinary Tract Infection 4.Catheter-Associated Urinary Tract Infection 5.Spinal cord injuries, trauma to the urogenital tract 6.Pregnant and lactating mothers.
  • 7.Patients below 18 years and above 70 years.

Outcomes

Primary Outcomes

Reduction in symptoms of UTI

Time Frame: 16 days

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
DrVaishali N
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Vishali N

Sri Jayendra Saraswathi Ayurveda College and Hospital, Nazarathpet

Study Sites (1)

Loading locations...

Similar Trials